Business Development & Partnership

Home > Business Development & Partnership

Hanmi Pharm. is dedicated to develop and provide innovative, valuable drugs to its customers. In order to pursue this goal, Hanmi is highly interested in collaborative opportunities including product in and out-licensing, co-research, co-development, co-promotion, and co-marketing with research institutes, pharmaceutical companies, and biotech companies domestically and internationally.

Global Licensing-out

Collaboration Model

  • (Straight) Licensing of Pipeline Products 
  • Early Stage Collaboration of Pipeline Products
  • Research Collaboration for application of Hanmi's Platform Technology

Partnering Strategy

Partnering Stage: Lead Optimization/Preclinical ~ Point of POC
Partnering Territory: Worldwide or Regional 
Partnering Company: Big Pharma or Biotech

Key Assets
Product Click to see more
LAPSCOVERY (Long Acting Biologics) Platform Technology & Pipeline
NCE Pipeline (Oncology / Metabolics / Autoimmune / etc.)